Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Published:2013-09 Issue:9 Volume:33 Page:2252-2260
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Woo Jong Shin¹,Kim Weon¹,Ha Sang Jin¹,Kim Jin Bae¹,Kim Soo-Joong¹,Kim Woo-Shik¹,Seon Hyun Ju¹,Kim Kwon Sam¹

Affiliation:

1. From the Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Republic of Korea (J.S.W., W.K., S.J.H., J.B.K., S.-J.K., W.-S.K., K.S.K.); and Department of Radiology, Chonnam National University Hospital, Gwangju, Republic of Korea (H.J.S).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. The Physiology of Glucagon-like Peptide 1

2. Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

3. Glucagon-like Peptide-1 and Myocardial Protection: More than Glycemic Control

4. Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury

5. A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life;Cardiac Failure Review;2024-09-11

2. The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes;Current Cardiology Reports;2024-09-05

3. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

4. Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease;2024-08-16

5. Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence;Current Pharmaceutical Design;2024-08